Related Experiment Videos
[Hepatitis as a travel disease]
J Hadem1, H Wedemeyer, M P Manns
1Abteilung für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover.
Der Internist
|May 1, 2004
Summary
Millions of travelers face viral hepatitis risks annually. This report details hepatitis A, E, and B risks, prevention, and treatment for international travelers.
Area of Science:
- Hepatology and Infectious Diseases
- Travel Medicine
- Public Health
Context:
- Over 50 million individuals from industrialized nations travel to regions with high viral hepatitis prevalence.
- Viral hepatitis transmission routes include oral-fecal and sexual contact.
- Risk factors vary by hepatitis type (A, E, B) and traveler's destination, duration, and behavior.
Purpose:
- To inform healthcare providers and travelers about the risks of viral hepatitis.
- To outline vaccination strategies, diagnostic criteria, and treatment protocols for viral hepatitis in travelers.
- To provide a comprehensive overview of hepatitis A, E, and B in the context of international travel.
Summary:
- Hepatitis A risk correlates with destination and living standards; Hepatitis E is common in Asia.
- Hepatitis B acquisition is linked to sexual behavior and unprotected intercourse.
- The report covers risk assessment, vaccinations, diagnostics, and acute hepatitis management for travelers.
Impact:
- Enhances traveler health by providing critical information on viral hepatitis prevention and management.
- Supports informed decision-making for pre-travel consultations and post-travel health monitoring.
- Contributes to reducing the burden of viral hepatitis in mobile populations globally.